BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19496119)

  • 1. Changing outcomes and treatment strategies for wire induced coronary perforations in the era of bivalirudin use.
    Kini AS; Rafael OC; Sarkar K; Rajdev S; Jakkula M; Mares AM; Kaplish D; Krishnan P; Kim MC; Sharma SK
    Catheter Cardiovasc Interv; 2009 Nov; 74(5):700-7. PubMed ID: 19496119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ''They can always hurt you more'' bivalirudin and the dynamic balance between bleeding and clotting.
    Morrison DA
    Catheter Cardiovasc Interv; 2009 Nov; 74(5):708-9. PubMed ID: 19856461
    [No Abstract]   [Full Text] [Related]  

  • 3. Failed pericardiocentesis for acute cardiac tamponade: two cases associated with bivalirudin administration during PCI.
    Al Shammeri OM; Crowell R; Stewart K; Fort S
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):114-6. PubMed ID: 19626695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regarding changing outcomes and treatment strategies for wire-induced coronary perforations in the era of bivalirudin use. A word of caution concerning the use of bivalirudin during coronary intervention for lesions at high risk for perforation.
    Movahed MR
    Catheter Cardiovasc Interv; 2011 Feb; 77(3):456; author reply 457-8. PubMed ID: 21328688
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of bivalirudin on in-hospital bleeding and six-month outcomes in octogenarians undergoing percutaneous coronary intervention.
    Lemesle G; De Labriolle A; Bonello L; Syed A; Collins S; Maluenda G; Torguson R; Kaneshige K; Xue Z; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):428-35. PubMed ID: 19360860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac tamponade complicating coronary perforation during angioplasty: short-term outcomes and long-term survival.
    Stathopoulos I; Kossidas K; Panagopoulos G; Garratt K
    J Invasive Cardiol; 2013 Oct; 25(10):486-91. PubMed ID: 24088420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of a prolonged bivalirudin infusion after urgent and complex percutaneous coronary interventions: a descriptive study.
    Cortese B; Micheli A; Picchi A; Bandinelli L; Brizi MG; Severi S; Limbruno U
    Coron Artery Dis; 2009 Aug; 20(5):348-53. PubMed ID: 19543084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
    Lincoff AM; Steinhubl SR; Manoukian SV; Chew D; Pollack CV; Feit F; Ware JH; Bertrand ME; Ohman EM; Desmet W; Cox DA; Mehran R; Stone GW;
    JACC Cardiovasc Interv; 2008 Dec; 1(6):639-48. PubMed ID: 19463378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of coronary arterial perforations during percutaneous coronary intervention with bivalirudin anticoagulation.
    Romaguera R; Sardi G; Laynez-Carnicero A; Ben-Dor I; Maluenda G; Wakabayashi K; Hauville C; Torguson R; Xue Z; Kent KM; Satler LF; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2011 Oct; 108(7):932-5. PubMed ID: 21784388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris.
    Steinberg DH; Shah P; Kinnaird T; Pinto Slottow TL; Roy PK; Okabe T; Bonello L; de Labriolle A; Smith KA; Torguson R; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2008 Jul; 102(2):160-4. PubMed ID: 18602514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of bivalirudin in patients with diabetes mellitus undergoing percutaneous coronary intervention in current clinical practice.
    Kim LK; Wong SC; Minutello RM; Bergman G; Feldman DN
    J Invasive Cardiol; 2010 Mar; 22(3):94-100. PubMed ID: 20197573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary intervention.
    Iijima R; Ndrepepa G; Mehilli J; Byrne RA; Schulz S; Neumann FJ; Richardt G; Berger PB; Schömig A; Kastrati A
    Eur Heart J; 2009 Feb; 30(3):290-6. PubMed ID: 19147609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery perforation in patients undergoing percutaneous coronary intervention: a single-centre report.
    Georgiadou P; Karavolias G; Sbarouni E; Adamopoulos S; Malakos J; Voudris V
    Acute Card Care; 2009; 11(4):216-21. PubMed ID: 19742353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial.
    Mehran R; Lansky AJ; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Kornowski R; Hartmann F; Gersh BJ; Pocock SJ; Wong SC; Nikolsky E; Gambone L; Vandertie L; Parise H; Dangas GD; Stone GW;
    Lancet; 2009 Oct; 374(9696):1149-59. PubMed ID: 19717185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Characteristics and Management of Coronary Artery Perforations: A Single-Center 11-Year Experience and Practical Overview.
    Lemmert ME; van Bommel RJ; Diletti R; Wilschut JM; de Jaegere PP; Zijlstra F; Daemen J; Van Mieghem NM
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of patient outcomes with bivalirudin versus unfractionated heparin in percutaneous coronary intervention.
    Watson K; Seybert AL; Saul MI; Lee JS; Kane-Gill SL
    Pharmacotherapy; 2007 May; 27(5):647-56. PubMed ID: 17461699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bivalirudin during primary PCI in acute myocardial infarction.
    Stone GW; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Kornowski R; Hartmann F; Gersh BJ; Pocock SJ; Dangas G; Wong SC; Kirtane AJ; Parise H; Mehran R;
    N Engl J Med; 2008 May; 358(21):2218-30. PubMed ID: 18499566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal trends, safety, and efficacy of bivalirudin in elective percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.
    Gurm HS; Smith DE; Chetcuti SJ; Share D; Khanal S; Riba A; Carter AJ; Lalonde T; Kline-Rogers E; O'Donnell M; O'Neill W; Safian R; Moscucci M;
    J Interv Cardiol; 2007 Jun; 20(3):197-203. PubMed ID: 17524111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oldies but goodies.
    Butman SM
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):436-7. PubMed ID: 19681122
    [No Abstract]   [Full Text] [Related]  

  • 20. Current incidence and clinical outcomes of bivalirudin administration among patients undergoing primary coronary intervention for stent thrombosis elevation acute myocardial infarction.
    Dauerman HL; Frederick PD; Miller D; French WJ;
    Coron Artery Dis; 2007 Mar; 18(2):141-8. PubMed ID: 17301606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.